Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Walz

Showing results (161-170 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomyFelix K-H Chun, Alberto Briganti, Claudio Jeldres, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter StudyAndrei Iagaru, Jose F Suarez, Spencer Behr, et al.
BJU International|February 13, 2010
The presence of prostate cancer on saturation biopsy can be accurately predictedSascha A Ahyai, Hendrik Isbarn, Pierre I Karakiewicz, et al.
European Urology|May 11, 2023
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer ConsortiumJohan Bjerner, Ola Bratt, Kirsti Aas, et al.
European Urology|March 27, 2007
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millenniumFelix K-H Chun, Alberto Briganti, Andrea Gallina, et al.
Urologic Oncology|August 27, 2019
"Real-world" evaluation of <sup>18</sup>F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategyVincent Niziers, Romain Boissier, Delphine Borchiellini, et al.
International Journal of Molecular Sciences|July 14, 2023
Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic ReviewAchille Aveta, Simone Cilio, Roberto Contieri, et al.
BJU International|May 6, 2008
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control studyJochen Walz, Shahrokh F Shariat, Nazareno Suardi, et al.
European Urology|January 14, 2014
Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutionsNazareno Suardi, Alessandro Larcher, Alexander Haese, et al.
European Urology Oncology|January 9, 2026
Best Practice in Preoperative Surgical Planning for Robotic-assisted Radical Prostatectomy: A European Consensus StatementElizabeth Day, Anders Bjartell, Ashwin Sridhar, et al.
Pageof 22

Showing results (161-170 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomyFelix K-H Chun, Alberto Briganti, Claudio Jeldres, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter StudyAndrei Iagaru, Jose F Suarez, Spencer Behr, et al.
BJU International|February 13, 2010
The presence of prostate cancer on saturation biopsy can be accurately predictedSascha A Ahyai, Hendrik Isbarn, Pierre I Karakiewicz, et al.
European Urology|May 11, 2023
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer ConsortiumJohan Bjerner, Ola Bratt, Kirsti Aas, et al.
European Urology|March 27, 2007
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millenniumFelix K-H Chun, Alberto Briganti, Andrea Gallina, et al.
Urologic Oncology|August 27, 2019
"Real-world" evaluation of <sup>18</sup>F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategyVincent Niziers, Romain Boissier, Delphine Borchiellini, et al.
International Journal of Molecular Sciences|July 14, 2023
Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic ReviewAchille Aveta, Simone Cilio, Roberto Contieri, et al.
BJU International|May 6, 2008
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control studyJochen Walz, Shahrokh F Shariat, Nazareno Suardi, et al.
European Urology|January 14, 2014
Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutionsNazareno Suardi, Alessandro Larcher, Alexander Haese, et al.
European Urology Oncology|January 9, 2026
Best Practice in Preoperative Surgical Planning for Robotic-assisted Radical Prostatectomy: A European Consensus StatementElizabeth Day, Anders Bjartell, Ashwin Sridhar, et al.
Pageof 22